Hot off the press last week was the inauguration of the 10th Annual Immuno-Oncology Summit. Creative Biolabs, one of the pioneering CROs, exhibited at the summit, October 12 to 14, presenting innovative solutions supportive of disease studies and immunotherapy development projects.
New York, United States - October 17, 2022 /MarketersMEDIA/ —
Hot off the heels of the news, the 10th Annual Immuno-Oncology Summit was back on stage, gathering hundreds of enthusiasts working in relevant areas to discuss the latest innovations and establish partnership opportunities. Creative Biolabs, a specialized provider of immuno-oncology services, is among those exhibiting at the grand summit (Booth #9), bringing expertise and capabilities in disease research and immunotherapy.
"It's the fifth conference we've participated in this year." According to one of the scientific delegates. "Even though things are busy in Q4 of 2022, we're still planning to implement more networking opportunities into our agenda."
Creative Biolabs has gathered a group of scientists with extensive experience in immuno-oncology studies and established a one-stop pipeline integrating frontier technologies and the most innovative methodologies to support projects for global customers involving new research targets, covering biomarkers and therapeutic routes. One example is the featured Next-IO™ HER3 therapeutic monoclonal antibody program, which goes after developing the HER3 therapeutic monoclonal antibodies for colorectal cancer immunotherapy.
"Even though huge achievements have been made in recent years, we still confront challenges during the development of novel immunotherapies," commented the delegate, "and what we do is not merely defining what immuno-oncology is, but finding ways to translate it into strategies and tools that can really help improve human health."
Onsite at the summit, scientific delegates from Creative Biolabs interacted with visitors who dropped by the booth over their projects, discussed possible solutions Creative Biolabs may provide to help ease problems they were facing, and learned a lot from the presentations of other companies working on the same track.
"We're amazed by what has been achieved so far in the field of IO and we did learn a lot. Despite the extensive practical experience gained through dozens of projects involving various diseases, we're continuously stretching our capabilities," added the delegate, "to keep pace with the latest breakthroughs and assist with the fight against emerging threatens to public health."
Learn more about Creative Biolabs and keep updated with Creative Biolabs' upcoming events at https://events.creative-biolabs.com/.
About
Creative Biolabs is a conscientious CRO working dedicatedly in the field of immunology, providing one-stop solutions to support the development of new drugs and assist with disease research. Since the beginning of 2022, a group of scientists from Creative Biolabs has embarked on the journey to several networking conferences, presenting their capabilities and seeking new partnership chances. In early December, Creative Biolabs will be exhibiting at the Antibody Engineering & Therapeutics (US) 2022 in San Diego.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/immuno-oncology/
Release ID: 89083193
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
